ANDREW STYPEREK MD

Treating your Skin cancer

TAMARAC

7301 N University Drive, Suite 102

Tamarac, FL 33321

Phone: 954-726-2000

Basal Cell Carcinoma (BCC)

Quick Facts

#1 cancer in America, ~ 2M cases annuallyNo precursor lesionAggressive and Non-aggressive subtypesLocal destructive growthMetastasis: < 1/1000

Squamous Cell Carcinoma

Quick Facts

#2 cancer, ~ 1M cases annuallyPrecursor lesions for most types of SCC

Lifetime risk of SCC if have pre-cancers: 6-10%Aggressive and Non-aggressive subtypesLocal destructive growth which may track

along nervesMetastasis: < 5%, up to 30% on lip or

genitals Related to depth, location, immunosuppression

Don’t let garden weeds become kudzu

Mohs: Choosing the best for your family

Certainty of removalPatient: Convenient & FastMedical: No lesion follow-up. Cost

effective.Minimize tissue removal

Certainty allows you to take smaller margins

Important for vital structures (nose, ears, eyelids, lips, etc.)

Experience is paramount

Non-surgical treatments offered by many dermatologists can lead to bigger problems

7cm

14cm

Initial Lesion

Mohs treatedLesion (20 yrs later)

The miMOHS™ experience

Minimal pain injections We offer topical numbing cream to apply at home Patient and gentle techniques to avoid the “stick and sting”

Creating a comfortable environment Friendly staff, relaxed atmosphere Bottle water and coffee, relaxing music, private waiting area

Subtle & sophisticated: Taking less tissue without compromising certainty Minimize surgical injury Minimal cautery smoke Simpler closures when possible, speeding post-operative healing

Instructions & Medications to treat residual pain post-procedure Antibiotics to prevent infection A personal emergency contact number A follow-up call to ensure comfort Scar revision

Chemical peel, dermabraision, or laser scar treatment

Not every tumor is the same…

Some are shallow

Which would you prefer? Shallow or Deep?

Vs.

miMOHS™

traditionalMOHS

Some tumors are deep

If the tumor is deep, we treat that too.

Melanoma in situ

Quick facts

Melanoma is #4 diagnosed cancer, ~ 74K in 2015 In-situ is #1 stage diagnosed, ~ 64K in 2015

Indolent (in elderly) vs. early aggressive tumor types

5-10 year survival ~ 99-100%Very low risk of metastasisTreated with excision only

Treating your Melanoma in situ

Excision of 5-10 mm margins Similar drawbacks as for BCC/SCC excision

Mohs with IHC Total margin control of Mohs + immunohistochemical

stains (MART-1) to track and identify positive margins at the time of excision

577 pt study, avg f/u 2.8 yrs: < 0.5% recurrence

MART-1 Stain

Using special stains, we track the melanoma tumor to ensure the tumor is out and the least tissue is sacrificed.